Regulacje i polityka gospodarcza · 22/09/2014

FDA to Grant Exclusive License for Direct Impact Corona Ionization Mass Spectrometry

The US Food and Drug Administration is considering granting an exclusive worldwide license to Vivione Biosciences, Inc. for the use of a patented technology related to direct impact corona ionization mass spectrometry, a tool for detecting small molecules and microbiological agents.